Home NDC 0480-5021 Clindamycin Phosphate and Benzoyl Peroxide
Product NDC 0480-5021
11-digit product format 004805021
Labeler code 0480
Product ID 0480-5021_8ba70028-3f0a-47ce-b545-fcc34b5bf0d5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Clindamycin Phosphate and Benzoyl Peroxide
Dosage form GEL
Route TOPICAL
Labeler Teva Pharmaceuticals, Inc.
Application ANDA208757
Marketing category ANDA
Marketing start 2026-11-18
Substance CLINDAMYCIN PHOSPHATE; BENZOYL PEROXIDE
Active strength 10; 37.5 mg/g; mg/g
Pharmacologic classes Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208757-001 CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE 3.75%;EQ 1.2% BASE GEL / TOPICAL AB 2026-08-07
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A208757-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A208757-001 CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE 3.75%;EQ 1.2% BASE GEL / TOPICAL AB 2026-08-07 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A208757-001 CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE 3.75%;EQ 1.2% BASE GEL / TOPICAL AB 2026-08-07 c2088c7a36db…2026-09-14 22:38:34 2026-08 A208757-001 CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE 3.75%;EQ 1.2% BASE GEL / TOPICAL AB 2026-08-07 84e616aacf4f…2026-08-18 06:07:40 2026-07 A208757-001 CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE 3.75%;EQ 1.2% BASE GEL / TOPICAL AB 2026-08-07 caaa826d4ba7…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 0480-5021-68 00480502168 1 BOTTLE, PUMP in 1 CARTON (0480-5021-68) / 50 g in 1 BOTTLE, PUMP 2026-11-18 No No Historical